A detailed history of Oakworth Capital, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Oakworth Capital, Inc. holds 3,802 shares of NVS stock, worth $405,977. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,802
Previous 3,808 0.16%
Holding current value
$405,977
Previous $384,000 4.43%
% of portfolio
0.03%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$95.27 - $108.47 $571 - $650
-6 Reduced 0.16%
3,802 $367,000
Q4 2023

Jan 30, 2024

SELL
$92.27 - $101.54 $461 - $507
-5 Reduced 0.13%
3,808 $384,000
Q3 2023

Oct 31, 2023

SELL
$94.73 - $105.13 $6,725 - $7,464
-71 Reduced 1.83%
3,813 $388,000
Q2 2023

Jul 28, 2023

SELL
$92.52 - $104.91 $4,626 - $5,245
-50 Reduced 1.27%
3,884 $391,000
Q1 2023

May 02, 2023

SELL
$80.03 - $92.81 $18,166 - $21,067
-227 Reduced 5.46%
3,934 $361,000
Q3 2022

Oct 31, 2022

SELL
$74.61 - $87.26 $4,476 - $5,235
-60 Reduced 1.42%
4,161 $316,000
Q1 2022

Apr 11, 2022

SELL
$80.11 - $90.62 $24,033 - $27,186
-300 Reduced 6.64%
4,221 $370,000
Q1 2021

Apr 30, 2021

SELL
$83.5 - $98.47 $1,920 - $2,264
-23 Reduced 0.51%
4,521 $386,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $8,197 - $9,915
-105 Reduced 2.26%
4,544 $429,000
Q3 2020

Nov 09, 2020

BUY
$82.14 - $91.0 $8,624 - $9,555
105 Added 2.31%
4,649 $404,000
Q2 2020

Aug 11, 2020

SELL
$80.93 - $91.1 $16,914 - $19,039
-209 Reduced 4.4%
4,544 $397,000
Q4 2019

Jan 31, 2020

SELL
$84.35 - $95.37 $16,448 - $18,597
-195 Reduced 3.94%
4,753 $449,000
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $34,472 - $37,986
-403 Reduced 7.53%
4,948 $430,000
Q2 2019

Aug 02, 2019

BUY
$75.4 - $92.8 $678 - $835
9 Added 0.17%
5,351 $489,000
Q3 2018

Oct 25, 2018

SELL
$66.94 - $77.43 $40,364 - $46,690
-603 Reduced 10.14%
5,342 $460,000
Q3 2017

Nov 08, 2017

BUY
$74.14 - $77.27 $440,762 - $459,370
5,945
5,945 $501,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Oakworth Capital, Inc. Portfolio

Follow Oakworth Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.